Dalliou M, Bonotis K
Cureus. 2025; 17(1):e77462.
PMID: 39958040
PMC: 11826494.
DOI: 10.7759/cureus.77462.
Egger J, Kaaya S, Swai P, Lawala P, Ndelwa L, Temu J
PLoS One. 2024; 19(6):e0304367.
PMID: 38889160
PMC: 11185462.
DOI: 10.1371/journal.pone.0304367.
Hao J, Tiles-Sar N, Habtewold T, Liemburg E, Bruggeman R, van der Meer L
Soc Psychiatry Psychiatr Epidemiol. 2024; 59(10):1733-1750.
PMID: 38456932
PMC: 11464570.
DOI: 10.1007/s00127-024-02630-4.
Vila-Barrios L, Carballeira E, Varela-Sanz A, Iglesias-Soler E, Dopico-Calvo X
Behav Sci (Basel). 2023; 13(12).
PMID: 38131815
PMC: 10740550.
DOI: 10.3390/bs13120959.
Ito S, Ohi K, Yasuda Y, Fujimoto M, Yamamori H, Matsumoto J
Schizophrenia (Heidelb). 2023; 9(1):78.
PMID: 37935686
PMC: 10630392.
DOI: 10.1038/s41537-023-00407-3.
Quality of life among people living with mental illness and predictors in Africa: a systematic review and meta-analysis.
Alemu W, Due C, Muir-Cochrane E, Mwanri L, Azale T, Ziersch A
Qual Life Res. 2023; 33(5):1191-1209.
PMID: 37906348
PMC: 11045618.
DOI: 10.1007/s11136-023-03525-8.
Pharmacological management of neurocognitive impairment in schizophrenia: A narrative review.
Arsenault-Mehta K, Hochman-Berard M, Johnson A, Semenova D, Nguyen B, Willis J
Neuropsychopharmacol Rep. 2023; 44(1):2-16.
PMID: 37794723
PMC: 10932777.
DOI: 10.1002/npr2.12382.
Health-related quality of life among patients with treated alcohol use disorders, schizophreniform disorders or affective disorders and the influence of flexible and integrative psychiatric care models in Germany (PsychCare).
Neumann A, Soltmann B, Kliemt R, Weinhold I, Schmitt J, Pfennig A
Front Psychiatry. 2023; 14:1068087.
PMID: 37065884
PMC: 10102371.
DOI: 10.3389/fpsyt.2023.1068087.
In Schizophrenia, the Effects of the IL-6/IL-23/Th17 Axis on Health-Related Quality of Life and Disabilities Are Partly Mediated by Generalized Cognitive Decline and the Symptomatome.
Al-Musawi A, Al-Hakeim H, Al-Khfaji Z, Al-Haboby I, Almulla A, Stoyanov D
Int J Environ Res Public Health. 2022; 19(22).
PMID: 36429996
PMC: 9690590.
DOI: 10.3390/ijerph192215281.
Quality of Life in Patients with Chronic Psychotic Disorders: A Practical Model for Interventions in Romanian Mental Health Centers.
Hurmuz M, Frandes M, Panfil A, Stoica I, Bredicean C, Giurgi-Oncu C
Medicina (Kaunas). 2022; 58(5).
PMID: 35630032
PMC: 9143751.
DOI: 10.3390/medicina58050615.
Effectiveness and Quality of Life with Paliperidone Palmitate 3-Monthly in Comparison with Other Long-Acting Drugs.
Di Lorenzo R, Iorio A, Pinelli M, Magarini F, Marchi M, Sacchetti A
Neuropsychiatr Dis Treat. 2022; 18:829-846.
PMID: 35440870
PMC: 9013412.
DOI: 10.2147/NDT.S356341.
Investigating the Role of Insight, Decision-Making and Mentalizing in Functional Outcome in Schizophrenia: A Cross-Sectional Study.
Escobedo-Aedo P, Forjan-Gonzalez A, Martinez A, Ruiz-Ruano V, Sanchez-Alonso S, Mata-Iturralde L
Behav Sci (Basel). 2022; 12(2).
PMID: 35200280
PMC: 8868582.
DOI: 10.3390/bs12020028.
Premorbid Social Functioning and Affective Symptoms Predict Subjective Outcome Among Outpatients With Schizophrenia.
Hoertnagl C, Kaufmann A, Yalcin-Siedentopf N, Pfaffenberger N, Frajo-Apor B, Pardeller S
Front Psychiatry. 2020; 11:570857.
PMID: 33192696
PMC: 7554309.
DOI: 10.3389/fpsyt.2020.570857.
Behavioral Tasks Evaluating Schizophrenia-like Symptoms in Animal Models: A Recent Update.
Ang M, Lee S, Kim J, Kim S, Moon C
Curr Neuropharmacol. 2020; 19(5):641-664.
PMID: 32798374
PMC: 8573744.
DOI: 10.2174/1570159X18666200814175114.
Quality of life and its association with psychiatric symptoms and socio-demographic characteristics among people with schizophrenia: A hospital-based cross-sectional study.
Desalegn D, Girma S, Abdeta T
PLoS One. 2020; 15(2):e0229514.
PMID: 32092123
PMC: 7039432.
DOI: 10.1371/journal.pone.0229514.
Gender differences in health-related quality of life in people with severe mental illness.
Colillas-Malet E, Prat G, Espelt A, Juvinya D
PLoS One. 2020; 15(2):e0229236.
PMID: 32084212
PMC: 7034846.
DOI: 10.1371/journal.pone.0229236.
Quality of Life-a Goal for Schizophrenia's Therapy.
Pirlog M, Alexandru D, Popescu R, Balcu L, Strunoiu L, Duica L
Curr Health Sci J. 2019; 44(2):122-128.
PMID: 30746158
PMC: 6320457.
DOI: 10.12865/CHSJ.44.02.05.
Supervised machine learning to decipher the complex associations between neuro-immune biomarkers and quality of life in schizophrenia.
Kanchanatawan B, Sriswasdi S, Maes M
Metab Brain Dis. 2018; 34(1):267-282.
PMID: 30467771
DOI: 10.1007/s11011-018-0339-7.
Systematic review of global functioning and quality of life in people with psychotic disorders.
Nevarez-Flores A, Sanderson K, Breslin M, Carr V, Morgan V, Neil A
Epidemiol Psychiatr Sci. 2018; 28(1):31-44.
PMID: 30270819
PMC: 7179814.
DOI: 10.1017/S2045796018000549.
The neural basis of hostility-related dimensions in schizophrenia.
Perlini C, Bellani M, Besteher B, Nenadic I, Brambilla P
Epidemiol Psychiatr Sci. 2018; 27(6):546-551.
PMID: 30208981
PMC: 6999008.
DOI: 10.1017/S2045796018000525.